These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 17172878

  • 1. Drug-eluting stents: preventing restenosis.
    Slavin L, Chhabra A, Tobis JM.
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I, Carrieri L, Catuzzo B, Destefanis P, Oliaro E, Moretti C, Trevi GP.
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sirolimus-eluting stents for the treatment of in-stent restenosis.
    Degertekin M, Saia F, Lemos PA, Arampatzis CA, Serruys PW.
    Minerva Cardioangiol; 2003 Oct; 51(5):475-84. PubMed ID: 14551517
    [Abstract] [Full Text] [Related]

  • 11. Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
    Silber S.
    J Interv Cardiol; 2004 Dec; 17(6):375-85. PubMed ID: 15546289
    [Abstract] [Full Text] [Related]

  • 12. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R, Mehilli J, Schömig A, Kastrati A.
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Classification and current treatment options of in-stent restenosis. Present status and future perspectives.
    Ong AT, Aoki J, McFadden EP, Serruys PW.
    Herz; 2004 Mar; 29(2):187-94. PubMed ID: 15057440
    [Abstract] [Full Text] [Related]

  • 15. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY, Lim YL.
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 17. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
    Schofer J, Bode C, Silber S.
    Herz; 2004 Mar 12; 29(2):195-200. PubMed ID: 15057441
    [Abstract] [Full Text] [Related]

  • 18. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.
    Chin Med J (Engl); 2007 Apr 05; 120(7):569-73. PubMed ID: 17442204
    [Abstract] [Full Text] [Related]

  • 19. Coronary restenosis after implantation of drug-eluting stents.
    Schofer J, Schlüter M.
    Minerva Cardioangiol; 2005 Feb 05; 53(1):43-8. PubMed ID: 15788978
    [Abstract] [Full Text] [Related]

  • 20. [Drug-eluting stents do they make the difference? ].
    Presbitero P, Asioli M.
    Minerva Cardioangiol; 2002 Oct 05; 50(5):431-42. PubMed ID: 12384625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.